Healthpeak Properties, Inc.
At today's price, Healthpeak Properties, Inc. (DOC) is priced for -3.0% FFO growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Healthpeak is the rare healthcare landlord whose rent comes from three different demand curves at once: outpatient medical buildings that fill up when doctors move out of hospitals, lab space tied to drug-development funding, and senior housing that tracks an aging population, and the March IPO of its senior-housing arm Janus Living (Healthpeak kept roughly 85% economic interest) turned part of that third leg into a separately traded position [Source: Janus Living IPO, March 2026]. • The sing
Is DOC overvalued? See what's priced in →
734 institutional managers reported holding DOC in 13F filings for the quarter ended 2026-03-31. Together they hold about 92% of the company; the top 10 hold 53%. 69 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 27.6M shares were sold short as of the 2026-06-15 count, about 4% of shares outstanding (4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
DOC's share count grew 29% over the past five years even with $363.93M spent on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting); the current rate is $1.22 a share annually. Cash returned over the past three years: $2.18B in dividends and $289.26M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at DOC over the trailing three years. Absence is a fact about the company, not a signal.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
DOC's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-29 | -2.2% | -15.5% |
| 2023-10-31 | -5.3% | +28.8% |
| 2024-02-10 | -3.0% | +6.8% |
| 2024-04-27 | +2.5% | +4.3% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
DOC's latest 8-K filings: 2026-05-05 (items 2.02, 7.01, 9.01); 2026-05-04 (items 5.07); 2026-03-23 (items 1.01, 2.03, 9.01); 2026-02-27 (items 7.01); 2026-02-02 (items 2.02, 7.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 28, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.